Heilongjiang ZBD Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Heilongjiang ZBD Pharmaceutical has a total shareholder equity of CN¥8.2B and total debt of CN¥3.3B, which brings its debt-to-equity ratio to 40.5%. Its total assets and total liabilities are CN¥12.7B and CN¥4.5B respectively. Heilongjiang ZBD Pharmaceutical's EBIT is CN¥685.3M making its interest coverage ratio -3. It has cash and short-term investments of CN¥966.2M.
Key information
40.5%
Debt to equity ratio
CN¥3.34b
Debt
| Interest coverage ratio | -3x |
| Cash | CN¥966.16m |
| Equity | CN¥8.25b |
| Total liabilities | CN¥4.45b |
| Total assets | CN¥12.70b |
Recent financial health updates
Heilongjiang ZBD Pharmaceutical (SHSE:603567) Seems To Use Debt Quite Sensibly
Sep 26
Does Heilongjiang ZBD Pharmaceutical (SHSE:603567) Have A Healthy Balance Sheet?
May 28Recent updates
We Like The Quality Of Heilongjiang ZBD Pharmaceutical's (SHSE:603567) Earnings
Nov 05Getting In Cheap On Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE:603567) Is Unlikely
Oct 18Heilongjiang ZBD Pharmaceutical (SHSE:603567) Seems To Use Debt Quite Sensibly
Sep 26Does Heilongjiang ZBD Pharmaceutical (SHSE:603567) Have A Healthy Balance Sheet?
May 28Why Heilongjiang ZBD Pharmaceutical's (SHSE:603567) Earnings Are Better Than They Seem
May 06Insufficient Growth At Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE:603567) Hampers Share Price
Apr 17Financial Position Analysis
Short Term Liabilities: 603567's short term assets (CN¥7.5B) exceed its short term liabilities (CN¥2.8B).
Long Term Liabilities: 603567's short term assets (CN¥7.5B) exceed its long term liabilities (CN¥1.7B).
Debt to Equity History and Analysis
Debt Level: 603567's net debt to equity ratio (28.8%) is considered satisfactory.
Reducing Debt: 603567's debt to equity ratio has reduced from 46% to 40.5% over the past 5 years.
Debt Coverage: 603567's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 603567 earns more interest than it pays, so coverage of interest payments is not a concern.